In line with this, mutations of Kristen rat sarcoma viral oncogene homolog (KRAS), an upstream regulator of the MEK/ERK pathway, confer EGFRi resistance in lung adenocarcinoma [129]. Here, MAPK1 is linked to lung adenocarcinoma.